Advance in Targeted Therapy and Immunotherapy for Lung Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 January 2026 | Viewed by 12
Special Issue Editor
Interests: thoracic malignancies; lung cancer; immunotherapy; targeted therapy; biomarkers; resistance mechanisms; EGFR/ALK inhibitors; tumor microenvironment; combination therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lung cancers, including small-cell lung cancer and non-small-cell lung cancer, remain among the leading causes of cancer-related mortality worldwide. Recent advances in targeted therapies and immunotherapies have significantly reshaped the therapeutic landscape, offering renewed hope for patients with advanced or treatment-resistant disease.
This Special Issue aims to showcase the latest research and clinical developments in precision oncology for lung cancer. We invite the submission of original research articles, reviews, and clinical perspectives focusing on the following topics:
- Molecular targets and resistance mechanisms;
- Novel immune checkpoint inhibitors;
- Biomarker discovery and validation;
- Combination treatment strategies;
- Real-world data on targeted and immune-based therapies.
Submissions addressing the integration of omics technologies, translational research, and innovative clinical trial designs are particularly encouraged.
By bringing together cutting-edge science and clinical insights, this Special Issue aims to provide a comprehensive overview of current advancements and future directions in the personalized treatment of lung cancer.
Dr. Walid Shalata
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- small-cell lung cancer
- non-small-cell lung cancer
- targeted therapy
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
